MedTrace Logo

Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study

NCT03890094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11158

Last updated 2019-04-02

No results posted yet for this study

Summary

The aim of this study was to determine the safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation. A retrospective analysis was conducted on all patients undergoing bronchoscopy applying sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017.

Conditions

  • Bronchoscopy
  • Sedation

Interventions

DRUG

Sufentanil

Patients were applied sufentanil and midazolam intravenously and topical anesthetized.

Sponsors & Collaborators

  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Principal Investigators

  • Shiyue Li, Professor · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-03-30
Completion
2018-05-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03890094 on ClinicalTrials.gov